Nature Medicine | Spoonful of Medicine

Results from two patients signals possible efficacy of stem cell-based eye therapy

Geron may have been the first company to launch a US trial with regulatory clearance involving a human embryonic stem cell (ESC)-derived product. But Advanced Cell Technology (ACT) made history itself today, becoming the first biotech to report results about such a product in a major peer-reviewed journal. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE